SGC001 injection

DRUG2 trials

Sponsors

Beijing Sungen Biomedical Technology Co., Ltd

Conditions

Acute Anterior ST-Segment Elevation Myocardial InfarctionAcute Pancreatitis

Phase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

RecruitingNCT07306182

Beijing Sungen Biomedical Technology Co., LtdAcute Anterior ST-Segment Elevation Myocardial Infarction

Start: 2026-03-09End: 2027-10-01Target: 210Updated: 2026-07-13

Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy

Not yet recruitingNCT07803965

Beijing Sungen Biomedical Technology Co., LtdAcute Pancreatitis

Start: 2026-09-01End: 2028-01-01Target: 129Updated: 2026-09-04